Amryt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMRYT, and when can generic versions of AMRYT drugs launch?
AMRYT has two approved drugs.
There are eighteen US patents protecting AMRYT drugs.
There are eighty patent family members on AMRYT drugs in twenty-eight countries and nineteen supplementary protection certificates in sixteen countries.
Drugs and US Patents for Amryt
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amryt | MYCAPSSA | octreotide acetate | CAPSULE, DELAYED RELEASE;ORAL | 208232-001 | Jun 26, 2020 | RX | Yes | Yes | 11,510,963 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-004 | Apr 23, 2015 | RX | Yes | No | 9,861,622 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | DISCN | Yes | No | 9,265,758 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-006 | Apr 23, 2015 | DISCN | Yes | No | 8,618,135 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | DISCN | Yes | No | 9,861,622 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-001 | Dec 21, 2012 | RX | Yes | No | 10,016,404 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Amryt
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-006 | Apr 23, 2015 | 5,712,279 | ⤷ Try a Trial |
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-005 | Apr 23, 2015 | 6,492,365 | ⤷ Try a Trial |
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-001 | Dec 21, 2012 | 5,712,279 | ⤷ Try a Trial |
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-002 | Dec 21, 2012 | 6,492,365 | ⤷ Try a Trial |
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-003 | Dec 21, 2012 | 5,739,135 | ⤷ Try a Trial |
Amryt | JUXTAPID | lomitapide mesylate | CAPSULE;ORAL | 203858-003 | Dec 21, 2012 | 5,712,279 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Amryt Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Cyprus | 1114218 | ⤷ Try a Trial |
European Patent Office | 3861986 | ⤷ Try a Trial |
Japan | 6258368 | ⤷ Try a Trial |
Japan | 2012502973 | ⤷ Try a Trial |
Cyprus | 1119148 | ⤷ Try a Trial |
Russian Federation | 2678833 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amryt Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1725234 | 1490006-2 | Sweden | ⤷ Try a Trial | PRODUCT NAME: LOMITAPID OCH FARMACEUTISKT GODTAGBARA SALTER DAERAV; REG. NO/DATE: EU/1/13/851/001 20130731 |
1725234 | SPC/GB14/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF OR THE PIPERIDINE N-OXIDE THEREOF; REGISTERED: UK EU/1/13/851/001 20130805; UK EU/1/13/851/002 20130805; UK EU/1/13/851/003 20130805 |
1725234 | 498 | Finland | ⤷ Try a Trial | |
1725234 | PA2014001,C1725234 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDAS; REGISTRATION NO/DATE: EU/1/13/851/001, 2013-07-31 EU/1/13/851/002, 2013-07-31 EU/1/13/851/003 20130731 |
1725234 | 14C0003 | France | ⤷ Try a Trial | PRODUCT NAME: LOMITAPIDE , OU UN SEL PHARMACEUTIQUEMENT ACTIF DE CELUI-CI.; REGISTRATION NO/DATE: EU/1/13/851/001 20130805 |
1725234 | CA 2014 00002 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LOMITAPID OG ENHVER TERAPEUTISK AEKVIVALENT FORM DERAF, SOM BESKYTTET I GRUNDPATENTET; REG. NO/DATE: EU/1/13/851/001-003 20130731 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.